Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Research Article

MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells

Wen-Jun Wang, Si-Pei Wu, Jin-Bin Liu, Yong-Sheng Shi, Xue Huang, Qian-Bing Zhang and Kai-Tai Yao
Wen-Jun Wang
Cancer Research Institute, Southern Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Si-Pei Wu
Cancer Research Institute, Southern Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin-Bin Liu
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong-Sheng Shi
Department of Anesthesiology, Nanfang Hospital, Southern Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xue Huang
Cancer Research Institute, Southern Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qian-Bing Zhang
Cancer Research Institute, Southern Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai-Tai Yao
Cancer Research Institute, Southern Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kaitaiyao@yahoo.cn
DOI: 10.1158/0008-5472.CAN-12-1408
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Radiotherapy is the most successful nonsurgical treatment for nasopharyngeal carcinoma (NPC). Despite this, the prognosis remains poor. Although NPCs initially respond well to a full course of radiation, recurrence is frequent. The cancer stem cell (CSC) hypothesis provides a framework for explaining the discrepancy between the response of NPC to therapy and the poor survival rate. In this study, a stem cell-like subpopulation (PKH26+) was identified in NPC cell lines using a label retention technique. PKH26+ cells were enriched for clonogenicity, sphere-formation, side-population cells, and resistance to radiotherapy. Using genomic approaches, we show that the proto-oncogene c-Myc (MYC) regulates radio-tolerance through transcriptional activation of Chk1 (CHEK1) and Chk2 (CHEK2) checkpoint kinases through direct binding to the Chk1 and Chk2 promoters. Overexpression of c-Myc in the PKH26+ subpopulation leads to increased expression of Chk1 and Chk2 and subsequent activation of the DNA damage checkpoint response, resulting in radioresistance. Furthermore, loss of Chk1 and Chk2 expression reverses radioresistance in PKH26+ (c-Myc high expression) cells in vitro and in vivo. This study elucidates the role of the c-Myc-Chk1/Chk2 axis in regulating DNA damage checkpoint responses and stem cell characteristics in the PKH26+ subpopulation. Furthermore, these data reveal a potential therapeutic application in reversal of radioresistance through inhibition of the c-Myc-Chk1/Chk2 pathway.

  • Received April 15, 2012.
  • Revision received November 2, 2012.
  • Accepted November 12, 2012.
  • Copyright © 2012, American Association for Cancer Research.
Next
Back to top

Published OnlineFirst January 9, 2013
doi: 10.1158/0008-5472.CAN-12-1408

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells
Wen-Jun Wang, Si-Pei Wu, Jin-Bin Liu, Yong-Sheng Shi, Xue Huang, Qian-Bing Zhang and Kai-Tai Yao
Cancer Res January 9 2013 DOI: 10.1158/0008-5472.CAN-12-1408

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells
Wen-Jun Wang, Si-Pei Wu, Jin-Bin Liu, Yong-Sheng Shi, Xue Huang, Qian-Bing Zhang and Kai-Tai Yao
Cancer Res January 9 2013 DOI: 10.1158/0008-5472.CAN-12-1408
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • MDA-9 mediates prostate cancer invasion
  • Targeting of MDSC increases efficiency of VEGFR-2 inhibitors
  • Enhancer remodeling in acquired resistance to ALK inhibitor
Show more Research Article
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement